Vepalimomab
Modify Date: 2024-01-13 17:24:19
Vepalimomab structure
|
Common Name | Vepalimomab | ||
|---|---|---|---|---|
| CAS Number | 195158-85-1 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of VepalimomabVepalimomab (Anti-Human AOC3 Recombinant Antibody) is a monoclonal antibody that blocks vascular adhesion protein 1 (VAP-1). Vepalimomab has anti-inflammatory effects[1]. |
| Name | Vepalimomab |
|---|
| Description | Vepalimomab (Anti-Human AOC3 Recombinant Antibody) is a monoclonal antibody that blocks vascular adhesion protein 1 (VAP-1). Vepalimomab has anti-inflammatory effects[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Vepalimomab (Anti-human-VAP-1 mAb 1B2; 3 mg/kg; i.v; once) 显示在发炎的皮肤和滑膜中上调[2]。 Vepalimomab (3 mg/kg; i.v) 显示初始快速分布相在猪体内的半衰期为 26 分钟，相应的消除相半衰期为 431 分钟[2]。 |
| References |
| No Any Chemical & Physical Properties |